Ash combines hands-on experience in new product development and market entry strategy with deep domain knowledge in cell and gene therapies. With a background in Biomedical Engineering and Innovation & Management, she brings a unique ability to dissect complex business challenges and engineer actionable, data-driven solutions. She has worked across the spectrum of biotech—from nimble startups to global pharma—partnering with teams to bring innovative therapies to market and optimize commercial strategy.